Further analysis revealed that the patients with an age ≥ 63 and no smoking history were more prone to EGFR mutations (P < 0.05), but there were no significant differences in nation and lymph node metastasis. Here, EGFR is linked to metastatic malignant neoplasm in the lymph nodes.